China SXT Pharmaceuticals, Inc.
SXTC
$4.12
$0.8224.99%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 81.90K | 81.90K | -3.18M | -3.18M | -1.25M |
| Total Depreciation and Amortization | 55.60K | 55.60K | 16.10K | 16.10K | 41.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 216.20K |
| Total Other Non-Cash Items | -571.00K | -571.00K | 2.79M | 2.79M | 611.40K |
| Change in Net Operating Assets | -698.80K | -698.80K | -496.30K | -496.30K | -112.70K |
| Cash from Operations | -1.13M | -1.13M | -876.30K | -876.30K | -494.10K |
| Capital Expenditure | -- | -- | -- | -- | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 12.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -163.20K | -163.20K | -462.30K | -462.30K | -- |
| Cash from Investing | -163.20K | -163.20K | -462.30K | -462.30K | 11.50K |
| Total Debt Issued | 106.80K | 106.80K | 153.50K | 153.50K | 154.70K |
| Total Debt Repaid | -130.60K | -130.60K | -57.70K | -57.70K | -919.90K |
| Issuance of Common Stock | 4.56M | 4.56M | 2.59M | 2.59M | 1.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -33.80K |
| Cash from Financing | 4.53M | 4.53M | 2.69M | 2.69M | 581.00K |
| Foreign Exchange rate Adjustments | 253.80K | 253.80K | 187.10K | 187.10K | -290.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.49M | 3.49M | 1.53M | 1.53M | -191.70K |